Skip to content 
Search

Latest Stories

NHS encouraged to provide cognitive behaviour therapy for menopause

This guidance highlights that CBT can assist with managing issues like hot flushes, sleep disturbances, and mood changes

NHS encouraged to provide cognitive behaviour therapy for menopause

The National Institute for Health and Care Excellence (NICE) has issued new draft guidance for the NHS, suggesting that women dealing with problematic menopause symptoms should have the option of receiving talking therapy, specifically cognitive behaviour therapy (CBT), in addition to or instead of hormone replacement therapy (HRT).

This guidance, marking the first update in nearly a decade, highlights that CBT can assist with managing issues like hot flushes, sleep disturbances, and mood changes, the BBC reports.


NICE believes that offering this choice will provide women with more alternatives. However, some critics have expressed disappointment with this recommendation.

According to NICE, there has been a clearer understanding of HRT since its last menopause guidance in 2015.

The updated guidelines outline the advantages and disadvantages of various available HRT formulations.

However, the new guidelines do not introduce any fresh recommendations regarding testosterone therapy, which certain menopausal women have sought from private clinics.

NICE advises women to select treatments from its guidelines that align best with their needs, evaluating the risks and benefits with the guidance of their physician.

NICE recommends using the lowest effective dose for HRT if individuals choose this option. The draft also suggests that women may consider individual or group talking therapy sessions, whether in-person or online.

Based on certain studies, CBT is indicated to teach coping skills that can alleviate menopause-related sleep issues, including improving the time it takes to sleep.

As women approach menopause, a stage marked by the permanent cessation of menstrual periods, their estrogen levels undergo fluctuations and decline. These hormonal changes often lead to troublesome symptoms.

HRT involves supplementing estrogen and occasionally other hormones, like progesterone, to alleviate symptoms experienced during menopause and maintain bone strength.

HRT comes in various formulations and delivery methods, such as oral tablets, skin patches, and gels. However, similar to any treatment, there may be side effects or heightened risks associated with its use.

The potential risks associated with HRT include several factors like increased likelihood of breast, ovarian, and uterine cancers and the possibility of blood clots, stroke, and dementia.

These risks vary significantly and depend on individual characteristics, including age, existing health conditions, and family history of these ailments.

For instance, women who have undergone a hysterectomy and no longer have a womb may not require additional progesterone alongside estrogen in their HRT as they are not susceptible to womb cancer.

NICE notes that among 1,000 women using estrogen-only HRT for ten years, there might be an estimated three extra cases of ovarian cancer on average.

In contrast, for 1,000 women using combined estrogen and progesterone HRT, there might be approximately one additional case.

According to NICE, using a skin patch or gel for the estrogen component in combined HRT does not heighten the risk of stroke, while taking it in tablet form slightly elevates this risk.

Additionally, if initiated after the age of 65, starting combined HRT may slightly increase the risk of dementia, the guidance said.

Testosterone, although primarily known as a male hormone, is also produced in women, and its levels can decrease during menopause.

There are claims from some women that taking testosterone alleviates several menopausal symptoms, such as brain fog.

NICE currently suggests considering it for low sexual desire if HRT alone proves ineffective. However, they do not recommend its use for other symptoms due to insufficient evidence.

Professor Gillian Baird, involved in crafting the guidance, highlighted its significance in providing evidence-based information for women and healthcare practitioners.

She emphasised that this guidance offers more choices for women to make informed decisions based on their individual circumstances.

The draft guidance is open for public consultation until January 5, 2024.

Dr Louise Newson, a GP and menopause specialist, expressed disappointment with the draft, noting that while CBT might help in managing some aspects of perimenopause, it might not improve every menopausal symptom or address underlying hormonal deficiencies.

Dr Newson also pointed out the absence of potential positive effects of HRT on conditions like heart disease and clinical depression from the document.

Highlighting the need for women's choices, she emphasised that those who wish to take HRT should have access to it, expressing concern that women are more commonly prescribed antidepressants than HRT.

The British Menopause Society welcomed the inclusion of CBT, emphasising its effectiveness and the importance of balancing the benefits and risks of HRT.

More For You

Ping Pong restaurant chain shuts all UK branches

The chain had also gained a following for its themed brunches

iStock

Ping Pong restaurant chain shuts all UK branches after 20 years

Key points

  • Chinese dim sum restaurant Ping Pong has closed all its UK locations
  • The chain made the announcement via social media
  • Founded in 2005, the brand thanked customers and staff for their support
  • Loyal diners shared memories and disappointment in the comments

All branches are permanently closed

Chinese restaurant chain Ping Pong has permanently closed all its branches in the UK, the company confirmed in a social media announcement.

Founded in 2005 by restaurateur Kurt Zdesar, the dim sum chain had become popular for its stylish interiors, creative menus, and Asian-inspired cocktails. The company did not provide prior notice of the closure but said the decision marked the end of an “unforgettable” 20-year journey.

Keep ReadingShow less
New Covid strain

Experts have raised concerns about the immune-evasive nature of the Stratus strain

iStock

New Covid strain Stratus spreads in UK with unusual hoarse voice symptom

Key points

  • A new Covid strain known as Stratus is spreading across the UK
  • The variant is marked by a distinctive symptom: a hoarse or raspy voice
  • Sub-variants XFG and XFG.3 now account for 30% of cases in England
  • Experts say there is no evidence of more severe disease
  • Lower immunity levels may make more people vulnerable to infection

Covid variant Stratus on the rise in the UK

A new strain of Covid-19, known as Stratus, is spreading across the UK and drawing attention for its unusual symptom — a hoarse or raspy voice. According to data from the UK Health Security Agency (UKHSA), Stratus and its two sub-variants, XFG and XFG.3, are responsible for around 30 per cent of Covid cases in England.

Of the two, XFG.3 is currently the more dominant. The UKHSA confirmed that monitoring of all circulating Covid-19 variants is ongoing as part of regular surveillance.

Keep ReadingShow less
Kent County Show 2025

Sophie, Duchess of Edinburgh, who grew up in Brenchley

Getty Images

Kent County Show opens with royal visit from Duchess of Edinburgh

Key points:

  • Day one of the Kent County Show begins at Detling Showground near Maidstone
  • The Duchess of Edinburgh visits the event for the first time in 16 years
  • Organisers expect up to 70,000 visitors over the weekend
  • Farming and rural life are at the centre of the three-day programme
  • Highlights include live camel racing, equine sports, livestock displays and more

Kent County Show opens with royal visit

The Kent County Show returned to Detling near Maidstone on Friday, marking the start of a major three-day celebration of farming, food, and rural living. The event opened with a special visit from the Duchess of Edinburgh, who is attending for the first time in 16 years.

Sophie, Duchess of Edinburgh, who grew up in Brenchley near Tunbridge Wells and serves as patron of the Association of Show and Agricultural Organisations (ASAO), met with farmers, equine exhibitors, and local businesses on her tour of the showground.

Keep ReadingShow less
Sri Aurobindo

Heehs’s biography is grounded in extensive archival research across France, England, India and Israel

AMG

Sri Aurobindo and the rise of the Asian century

Dinesh Sharma

My friend and colleague, the American historian Peter Heehs, who has lived in Pondicherry, India, for decades, recently published a compelling new biography, The Mother: A Life of Sri Aurobindo’s Collaborator (2025). Heehs previously authored The Lives of Sri Aurobindo (2008), which remains one of the most balanced and scholarly accounts of Aurobindo’s life.

According to Heehs, most previous biographies of the Mother were written for devotees and relied on secondary sources, often presenting her as a divine incarnation without critical engagement. “Such biographies are fine for those who see the Mother as a divine being,” Heehs said, “but they can be off-putting for readers who simply want to understand her life – as an artist, writer, spiritual teacher, and founder of the Ashram and Auroville.”

Keep ReadingShow less
Black women cancer risk

Serious public health challenges in the decades ahead

iStock

Study warns of rising uterine cancer rates, with Black women hardest hit

Key points

  • Uterine cancer cases and deaths are projected to rise significantly in the US by 2050.
  • Black women are expected to experience the highest increase in incidence-based mortality.
  • A new model predicts incidence rising to 86.9 cases per 100,000 for Black women and 74.2 for White women.
  • Researchers stress the urgent need for improved prevention and early detection strategies.

Sharp increase in uterine cancer predicted over next three decades

Uterine cancer, currently the fourth most commonly diagnosed cancer among women in the United States, is projected to see a substantial rise in both cases and deaths by 2050, particularly among Black women. A new study led by researchers at Columbia University warns of worsening racial disparities in outcomes if preventative measures are not introduced.

This year alone, around 69,120 new cases of uterine cancer and nearly 14,000 deaths are expected in the United States. However, projections by the Columbia University research team, published in Cancer Epidemiology, Biomarkers & Prevention, indicate a significant increase in both incidence and mortality over the next 30 years.

Keep ReadingShow less